FGFR2 is amplified in the NCI-H716 colorectal cancer cell line and is required for growth and survival.
about
Correlation of human epidermal growth factor receptor protein expression and colorectal cancerPreclinical Activity of ARQ 087, a Novel Inhibitor Targeting FGFR DysregulationTherapeutic aspects of c-MYC signaling in inflammatory and cancerous colonic diseasesIn vitro and in vivo evaluation of the radiosensitizing effect of a selective FGFR inhibitor (JNJ-42756493) for rectal cancerThe impact of RNA binding motif protein 4-regulated splicing cascade on the progression and metabolism of colorectal cancer cells.Fibroblast growth factor receptor 2 expression, but not its genetic amplification, is associated with tumor growth and worse survival in esophagogastric junction adenocarcinoma.Target and Agent Prioritization for the Children's Oncology Group-National Cancer Institute Pediatric MATCH Trial.Targeting FGF receptors in colorectal cancer: from bench side to bed side.FGFR2 Amplification in Colorectal Adenocarcinoma.The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets.Fibroblast Growth Factors in the Gastrointestinal Tract: Twists and Turns.Autophagy inhibition enhances colorectal cancer apoptosis induced by dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235.Exploring the mechanism of WWOX growth inhibitory effects on oral squamous cell carcinomaFGFR2 regulation by picrasidine Q inhibits the cell growth and induces apoptosis in esophageal squamous cell carcinoma.Generation of high-affinity, internalizing anti-FGFR2 single-chain variable antibody fragment fused with Fc for targeting gastrointestinal cancers.AZD-4547 exerts potent cytostatic and cytotoxic activities against fibroblast growth factor receptor (FGFR)-expressing colorectal cancer cells.The Risk Factors Affecting Survival in Colorectal Cancer in Taiwan.
P2860
Q26801167-7CE71BA6-792E-45B8-8847-88247E734A2AQ27322795-1D96BA70-A5C4-488E-8858-288FC74DC5D0Q28071309-7DDDD473-0E3F-4AFC-9347-BBE10148FB49Q35870855-C3615E84-81D2-4B8E-8F84-C34168218EFFQ36545961-7160D5A4-2B69-40D9-9E64-0FE450B790F7Q37190164-5FBF0F3D-9EED-400D-9251-302BCD9C8F60Q38371672-CB9772AD-E0BE-49A5-B1B8-DBBBFC8C8B3CQ38465837-8DABB1B7-50FC-4FD5-BA60-E6B910ACE1D8Q38694309-174DAC5C-55A5-4C8B-88D0-DEBA023623E9Q38880745-422E6DF8-BFC9-4C0B-83DA-9D09F06D3C21Q39136136-B5C2F282-618B-4807-966B-7FC9586BC8D1Q41914792-4474F3EE-692F-4DB9-8E97-A6E2C64209EBQ42267478-02DD98ED-93E2-418A-B474-7DB30C8CEC5CQ46313987-4D1B7018-74FF-4F48-8106-F5A1D6BE8497Q50114183-2DF478FD-1376-47C6-9B3E-B8C532C6B928Q52966220-598717CC-E4F3-48DB-9484-EDCD43A01883Q55128830-4761B06B-D8D8-44EA-99A6-8EA81E350432
P2860
FGFR2 is amplified in the NCI-H716 colorectal cancer cell line and is required for growth and survival.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
FGFR2 is amplified in the NCI- ...... uired for growth and survival.
@ast
FGFR2 is amplified in the NCI- ...... uired for growth and survival.
@en
type
label
FGFR2 is amplified in the NCI- ...... uired for growth and survival.
@ast
FGFR2 is amplified in the NCI- ...... uired for growth and survival.
@en
prefLabel
FGFR2 is amplified in the NCI- ...... uired for growth and survival.
@ast
FGFR2 is amplified in the NCI- ...... uired for growth and survival.
@en
P2093
P2860
P1433
P1476
FGFR2 is amplified in the NCI- ...... uired for growth and survival.
@en
P2093
Adi Gazdar
Anjili Mathur
Bart Lutterbach
Bo-Sheng Pan
Christopher Ware
Lenora Davis
P2860
P304
P356
10.1371/JOURNAL.PONE.0098515
P407
P577
2014-06-26T00:00:00Z